Drug Delivery Markets, Vol. IV: Transdermal and Transmucosal Drug Delivery


April 1, 2007
118 Pages - SKU: KLI1399450
License type:
Chapter One: Executive Summary
  • Market Drivers
  • Market Size and Growth
    • Total Transdermal/Transmucosal Drug Delivery Market
    • Transdermal/Transmucosal Drug Delivery Only Market
    • Competitive and Market Analysis

Chapter Two: Introduction and Overview

  • Scope and Methodology
  • Reasons for Transdermal/Transmucosal Drug Delivery Systems
  • History of Transdermal and  Transmucosal Drug Delivery
  • Phases of Drug Action
  • Topical Drug Delivery
    • Types of Topical Preparations
    • Market Participants
    • Transdermal Patch Drug Delivery
      • Membrane-Controlled System
      • Adhesive Dispersion-Type System
      • Matrix Diffusion-Controlled System
      • Microreservoir Dissolution-Controlled System
      • New Transdermal Drug Applications and Approvals
      • Electrotransport Drug Delivery
      • Iontophoresis
      • Transmucosal Drug Delivery
        • Oral Transmucosal Fentanyl Citrate (OTFC)
        • Transmucosal Etomidate
        • Ondansetron ODT
        • Buccal Drug Delivery
        • Vaginal Drug Delivery

Chapter three: Trends and Developments

  • Innovations in Transdermal Drug Delivery
  • Adhesive Technology and Issues
  • Adhesive Market Issues
  • Biotechnological Issues
  • Iontophoresis and Sonophoresis
  • Developments in Insulin Delivery
  • New Developments in Hormone Drug Delivery
  • New Mucosal/Buccal Delivery Systems
  • Other New Drug Delivery Systems
  • Macroflux Technology
  • Controlled Thermal Energy Technology
  • New Ultrasound Technology
  • Combination Delivery Technology
  • Transdermal Products in Development

Chapter four: Market Size and Growth

  • The Total Transdermal/Transmucosal Drug Delivery Market
  • Transdermal/Transmucosal Delivery Technology Only Market

chapter five: Competitive Analysis

  • Competitive Landscape
  • Market Analysis

CHAPTER SIX: Company Profiles

  • 3M Pharmaceuticals
  • Acrux Limited
  • Altea Therapeutics, Inc
  • ALZA Corporation
  • Antares Pharma, Inc.
  • Aveva Drug Delivery Systems
  • Cardinal Health
  • Cephalon Inc
  • Generex Biotechnology Corporation
  • Inovio  Biomedical Corporation
  • Labtec GmbH
  • Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG)................
  • MacroChem Corporation
  • NexMed, Inc.
  • Noven Pharmaceuticals, Inc.
  • SkyePharma PLC

Appendix
Company Directory
Table of exhibits
chapter twO: Introduction and Overview

  • Table 2-1: Sequence of Drug Action

Chapter three: Trends and Developments

  • Table 3-1: Selected Transdermal Products in Development

Chapter four: Market Size and Growth

  • Table 4-1: The Worldwide Market for Transdermal/Transmucosal Drug Delivery  Technology and Pharmaceuticals 2002-2010
  • Figure 4-1.. : The Worldwide Market for Transdermal/Transmucosal Drug Delivery  Technology and Pharmaceuticals 2002-2010
  • Table 4-2: The Worldwide Market for Pharmaceuticals Utilizing Transdermal/ Transmucosal Drug Delivery Systems by Type 2002-2010
  • Figure 4-2: The Worldwide Market for Pharmaceuticals Utilizing Transdermal/ Transmucosal Drug Delivery Systems Revenues by Type 2002-2010
  • Table 4-3: The Worldwide Market for Pharmaceuticals Utilizing Transdermal/ Transmucosal Drug Delivery Technologies Market Share by Type 2002-2010.......
  • Figure 4-3: The Worldwide Market for Pharmaceuticals Utilizing Transdermal/ Transmucosal Drug Delivery Technologies by Type 2006
  • Figure 4-4: The Worldwide Market for Pharmaceuticals Utilizing Transdermal/ Transmucosal Drug Delivery Technologies by Type 2010
  • Table 4-4: The Worldwide Market for Transdermal/Transmucosal Drug Delivery  Systems by Pharmaceutical and  Drug Delivery Component 2002-2010
  • Table 4-5: The Worldwide Market for Transdermal/Transmucosal Drug Delivery Systems Distribution of Revenue by Pharmaceutical  and Drug Delivery Component 2002-2010
  • Figure 4-5.. : The Worldwide Market for Transdermal/Transmucosal Drug Delivery Systems Distribution of Revenue by Pharmaceutical and Drug Delivery Component 2002-2010          
  • Figure 4-6: The Worldwide Market for Transdermal/Transmucosal Drug Delivery  Systems Distribution of Revenue by Pharmaceutical and Drug Delivery  Component 2006
  • Figure 4-7: The Worldwide Market for Transdermal/Transmucosal Drug Delivery  Systems Distribution of Revenue by Pharmaceutical and Drug Delivery Component 2010

chapter five: Competitive Analysis

  • Table 5-1: Leading Suppliers of Transdermal/Transmucosal Drug  Delivery Technology